 OncLive | Numerous Drug Classes Studied for Use in Follicular Lymphoma OncLive Ofatumumab, a humanized monoclonal anti-CD20 antibody approved under the trade name Arzerra for use in chronic lymphocytic leukemia (CLL), has shown some promise as a single agent in patients with rituximab-resistant FL. In a study of patients with ... |
